Pacific Biosciences of California 관리
관리 기준 확인 2/4
Pacific Biosciences of California CEO는 Christian O. Henry, Sep2020 에 임명되었습니다 의 임기는 4.17 년입니다. 총 연간 보상은 $ 8.05M, 8.6% 로 구성됩니다. 8.6% 급여 및 91.4% 보너스(회사 주식 및 옵션 포함). 는 $ 860.82K 가치에 해당하는 회사 주식의 0.14% 직접 소유합니다. 860.82K. 경영진과 이사회의 평균 재임 기간은 각각 4 년과 11.8 년입니다.
주요 정보
Christian O. Henry
최고 경영자
US$8.0m
총 보상
| CEO 급여 비율 | 8.6% |
| CEO 임기 | 4.2yrs |
| CEO 소유권 | 0.1% |
| 경영진 평균 재임 기간 | 4yrs |
| 이사회 평균 재임 기간 | 11.8yrs |
최근 관리 업데이트
Recent updates
Pacific Biosciences' Cost Cuts Won't Offset Rising Competition
Nov 12Pacific Biosciences of California, Inc. (NASDAQ:PACB) Stock Rockets 56% But Many Are Still Ignoring The Company
Nov 07
Health Check: How Prudently Does Pacific Biosciences of California (NASDAQ:PACB) Use Debt?
Oct 16Even With A 37% Surge, Cautious Investors Are Not Rewarding Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Performance Completely
Sep 20Pacific Biosciences: A Speculative Play On Long-Read Genomics Sequencing
Aug 21Take Care Before Jumping Onto Pacific Biosciences of California, Inc. (NASDAQ:PACB) Even Though It's 33% Cheaper
Jul 02We Think Pacific Biosciences of California (NASDAQ:PACB) Has A Fair Chunk Of Debt
Jun 08Pacific Biosciences: Navigating Rough Waters In Gene Sequencing Seas
Jun 03These Analysts Think Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Sales Are Under Threat
Apr 25It's Down 25% But Pacific Biosciences of California, Inc. (NASDAQ:PACB) Could Be Riskier Than It Looks
Apr 16Pacific Biosciences' Pivot: From Shareholder Dilution To Expansion And Leadership
Mar 19Pacific Biosciences: Strong Cash And Doubling Revenue Signal Investment Growth
Feb 08With A 34% Price Drop For Pacific Biosciences of California, Inc. (NASDAQ:PACB) You'll Still Get What You Pay For
Feb 01What You Can Learn From Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) P/S
Dec 18Does Pacific Biosciences of California (NASDAQ:PACB) Have A Healthy Balance Sheet?
Nov 13The Price Is Right For Pacific Biosciences of California, Inc. (NASDAQ:PACB) Even After Diving 27%
Aug 28Is Pacific Biosciences of California, Inc. (NASDAQ:PACB) Trading At A 32% Discount?
Jul 31Is It Time To Consider Buying Pacific Biosciences of California, Inc. (NASDAQ:PACB)?
Jul 06Pacific Biosciences of California (NASDAQ:PACB) Is Carrying A Fair Bit Of Debt
May 25Is Now The Time To Look At Buying Pacific Biosciences of California, Inc. (NASDAQ:PACB)?
Mar 29Is Pacific Biosciences of California, Inc. (NASDAQ:PACB) Worth US$8.8 Based On Its Intrinsic Value?
Feb 26CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$394m |
| Jun 30 2024 | n/a | n/a | -US$400m |
| Mar 31 2024 | n/a | n/a | -US$297m |
| Dec 31 2023 | US$8m | US$695k | -US$307m |
| Sep 30 2023 | n/a | n/a | -US$309m |
| Jun 30 2023 | n/a | n/a | -US$319m |
| Mar 31 2023 | n/a | n/a | -US$321m |
| Dec 31 2022 | US$7m | US$667k | -US$314m |
| Sep 30 2022 | n/a | n/a | -US$299m |
| Jun 30 2022 | n/a | n/a | -US$206m |
| Mar 31 2022 | n/a | n/a | -US$175m |
| Dec 31 2021 | US$3m | US$650k | -US$181m |
| Sep 30 2021 | n/a | n/a | -US$37m |
| Jun 30 2021 | n/a | n/a | -US$77m |
| Mar 31 2021 | n/a | n/a | -US$59m |
| Dec 31 2020 | US$13m | US$195k | US$29m |
| Sep 30 2020 | n/a | n/a | -US$46m |
| Jun 30 2020 | n/a | n/a | -US$51m |
| Mar 31 2020 | n/a | n/a | -US$53m |
| Dec 31 2019 | US$100k | n/a | -US$84m |
| Sep 30 2019 | n/a | n/a | -US$115m |
| Jun 30 2019 | n/a | n/a | -US$111m |
| Mar 31 2019 | n/a | n/a | -US$109m |
| Dec 31 2018 | US$88k | n/a | -US$103m |
보상 대 시장: Christian O. 의 총 보상 ($USD 8.05M )은 US 시장( $USD 3.18M ).
보상과 수익: 회사가 수익성이 없는 동안 Christian O. 의 보상이 증가했습니다.
CEO
Christian O. Henry (56 yo)
4.2yrs
테뉴어
US$8,046,575
보상
Mr. Christian O. Henry, MBA, served as Independent Director at CM Life Sciences III Inc. since April 07, 2021 until December 2021. He has been President and Chief Executive Officer at Pacific Biosciences o...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President | 4.2yrs | US$8.05m | 0.14% $ 860.8k | |
| Chief Financial Officer | 4.2yrs | US$2.52m | 0.043% $ 262.0k | |
| Chief Operating Officer | 3.8yrs | US$4.60m | 0.12% $ 701.0k | |
| Chief Commercial Officer | 2.3yrs | US$2.53m | 0.050% $ 299.7k | |
| Co-Founder | 24.3yrs | US$466.76k | 데이터 없음 | |
| VP & Chief Accounting Officer | 3.5yrs | 데이터 없음 | 0.013% $ 80.3k | |
| General Counsel & Corporate Secretary | no data | 데이터 없음 | 데이터 없음 | |
| Chief People Officer | no data | 데이터 없음 | 데이터 없음 |
4.0yrs
평균 재임 기간
49.5yo
평균 연령
경험이 풍부한 관리: PACB 의 관리팀은 경험 ( 4 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President | 6.3yrs | US$8.05m | 0.14% $ 860.8k | |
| Independent Director | 20.8yrs | US$259.00k | 0.0069% $ 41.7k | |
| Independent Director | 12.2yrs | US$255.00k | 0% $ 0 | |
| Independent Chairman | 11.3yrs | US$297.00k | 0.040% $ 243.7k | |
| Member of the Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of the Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Independent Director | 15.8yrs | US$265.00k | 0% $ 0 | |
| Member of the Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of the Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of the Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of the Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Chairman of Scientific Advisory Board | 2yrs | 데이터 없음 | 데이터 없음 |
11.8yrs
평균 재임 기간
70yo
평균 연령
경험이 풍부한 이사회: PACB 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 11.8 년).